Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 107001-107050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03708731
Exploring Adherence Monitoring in Sickle Cell Disease
N/A
Active, not recruiting
36 participants
Started: Mar 12, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT03493425
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
PHASE2
Recruiting
82 participants
Started: Mar 12, 2019 · Completed: Mar 31, 2029
2 conditions
2 sponsors
140 locations
NCT03713580
Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma
PHASE1
Active, not recruiting
25 participants
Started: Mar 12, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT03718325
Burst Spinal Cord Stimulation (Burst-SCS) Study
NA
Recruiting
20 participants
Started: Mar 12, 2019 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT03843359
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
PHASE1
Active, not recruiting
97 participants
Started: Mar 12, 2019 · Completed: Mar 31, 2025
1 condition
1 sponsor
13 locations
NCT03855722
Remote Ischaemic Preconditioning in Transplantation (RIPTRANS)
NA
Recruiting
496 participants
Started: Mar 12, 2019 · Completed: Feb 28, 2042
1 condition
4 sponsors
1 location
NCT05161702
Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).
N/A
Recruiting
200 participants
Started: Mar 12, 2019 · Completed: Jan 1, 2026
2 conditions
1 sponsor
1 location
NCT03664609
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
N/A
Recruiting
5,000 participants
Started: Mar 12, 2019 · Completed: Dec 31, 2028
3 conditions
1 sponsor
19 locations
NCT03785080
Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients
NA
Recruiting
552 participants
Started: Mar 11, 2019 · Completed: Dec 30, 2025
1 condition
1 sponsor
3 locations
NCT03549273
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
PHASE2
Recruiting
62 participants
Started: Mar 11, 2019 · Completed: Jan 15, 2025
5 conditions
1 sponsor
1 location
NCT03769766
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
PHASE3
Recruiting
291 participants
Started: Mar 11, 2019 · Completed: Nov 30, 2030
1 condition
1 sponsor
1 location
NCT03809780
Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone
PHASE2
Active, not recruiting
70 participants
Started: Mar 11, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03666000
Dose-escalation, Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Patients With r/r NHL and r/r B-cell ALL
PHASE1
Recruiting
129 participants
Started: Mar 11, 2019 · Completed: Jun 30, 2027
2 conditions
1 sponsor
22 locations
NCT03401398
Stress Hydrocortisone In Pediatric Septic Shock
PHASE3
Recruiting
500 participants
Started: Mar 11, 2019 · Completed: Dec 31, 2026
1 condition
5 sponsors
44 locations
NCT03850574
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
PHASE1/PHASE2
Recruiting
240 participants
Started: Mar 11, 2019 · Completed: Apr 30, 2027
5 conditions
1 sponsor
34 locations
NCT03708003
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL
PHASE2
Active, not recruiting
30 participants
Started: Mar 11, 2019 · Completed: Dec 31, 2026
3 conditions
1 sponsor
11 locations
NCT03858205
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
NA
Recruiting
100 participants
Started: Mar 11, 2019 · Completed: Mar 11, 2027
3 conditions
2 sponsors
9 locations
NCT04050956
French Cohort of Myocardial Infarction Evaluation
N/A
Recruiting
30,000 participants
Started: Mar 11, 2019 · Completed: Mar 22, 2049
1 condition
2 sponsors
1 location
NCT03827317
HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer
NA
Recruiting
24 participants
Started: Mar 8, 2019 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT03708224
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
PHASE2
Recruiting
55 participants
Started: Mar 8, 2019 · Completed: Jun 30, 2028
4 conditions
3 sponsors
1 location
NCT03886584
Source Monitoring Déficit in Neuropsychiatric Population
NA
Recruiting
300 participants
Started: Mar 8, 2019 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT03701399
Troriluzole in Adult Participants With Spinocerebellar Ataxia
PHASE3
Active, not recruiting
299 participants
Started: Mar 8, 2019 · Completed: Oct 31, 2025
8 conditions
1 sponsor
23 locations
NCT04496687
"International Spontaneous Coronary Artery Dissection (SCAD) iSCAD Registry"
N/A
Recruiting
1,000 participants
Started: Mar 8, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
31 locations
NCT03892265
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
N/A
Active, not recruiting
3,005 participants
Started: Mar 8, 2019 · Completed: Aug 1, 2028
14 conditions
3 sponsors
1 location
NCT03789110
NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
PHASE2
Active, not recruiting
30 participants
Started: Mar 8, 2019 · Completed: Dec 30, 2025
1 condition
2 sponsors
3 locations
NCT03935763
Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
N/A
Active, not recruiting
738 participants
Started: Mar 8, 2019 · Completed: Nov 30, 2024
1 condition
1 sponsor
18 locations
NCT03640026
Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
PHASE4
Recruiting
30 participants
Started: Mar 8, 2019 · Completed: Jul 31, 2026
1 condition
1 sponsor
2 locations
NCT03972514
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
N/A
Active, not recruiting
60 participants
Started: Mar 8, 2019 · Completed: Mar 31, 2030
3 conditions
2 sponsors
1 location
NCT03669055
Hemodynamic Changes in the Aorta After Endovascular Treatment of the Aortic Dissection
NA
Recruiting
6 participants
Started: Mar 7, 2019 · Completed: Nov 7, 2025
1 condition
1 sponsor
1 location
NCT03671148
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
PHASE3
Active, not recruiting
444 participants
Started: Mar 7, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
138 locations
NCT03837899
Durvalumab and Tremelimumab for Pediatric Malignancies
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Mar 7, 2019 · Completed: Dec 30, 2024
3 conditions
1 sponsor
19 locations
NCT03355105
Comparison of Two Methods of Adjusting the Mechanical In-Exsuflation in Neuromuscular Adult Patients
NA
Active, not recruiting
29 participants
Started: Mar 7, 2019 · Completed: Dec 24, 2024
1 condition
1 sponsor
1 location
NCT03728673
A Study Utilizing Escitalopram in Glioma Patients
PHASE2
Recruiting
20 participants
Started: Mar 6, 2019 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT04740398
A Study of CBP-1008 in Patients With Advanced Solid Tumor
PHASE1
Recruiting
143 participants
Started: Mar 6, 2019 · Completed: Sep 30, 2024
1 condition
1 sponsor
3 locations
NCT03833154
Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation
PHASE3
Active, not recruiting
724 participants
Started: Mar 6, 2019 · Completed: Apr 4, 2028
1 condition
1 sponsor
209 locations
NCT03617679
Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer
PHASE2
Active, not recruiting
79 participants
Started: Mar 6, 2019 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT04637256
Evaluation of Outcomes from Treatment of Benign or Malignant Gastroesophageal Diseases
N/A
Recruiting
500 participants
Started: Mar 6, 2019 · Completed: Jan 30, 2025
1 condition
1 sponsor
1 location
NCT03697356
R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia
PHASE2
Recruiting
54 participants
Started: Mar 6, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03732950
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
PHASE2
Active, not recruiting
5 participants
Started: Mar 6, 2019 · Completed: Mar 6, 2025
3 conditions
2 sponsors
3 locations
NCT03610711
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
PHASE1/PHASE2
Active, not recruiting
21 participants
Started: Mar 6, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
3 locations
NCT04489693
Comprehensive Care Community and Culture Study
NA
Recruiting
3,000 participants
Started: Mar 6, 2019 · Completed: Jul 31, 2029
4 conditions
2 sponsors
1 location
NCT03696225
Assessment and Treatment of Cognitive Functioning Deficits in Veterans With PTSD
NA
Active, not recruiting
21 participants
Started: Mar 6, 2019 · Completed: Dec 29, 2025
1 condition
1 sponsor
1 location
NCT03833700
A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)
PHASE1
Active, not recruiting
70 participants
Started: Mar 5, 2019 · Completed: Jan 31, 2026
3 conditions
1 sponsor
8 locations
NCT04287400
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
N/A
Recruiting
210 participants
Started: Mar 5, 2019 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT03866109
A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMT
PHASE1/PHASE2
Recruiting
27 participants
Started: Mar 5, 2019 · Completed: Dec 9, 2025
1 condition
1 sponsor
3 locations
NCT04141592
Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
N/A
Recruiting
153 participants
Started: Mar 5, 2019 · Completed: Apr 1, 2026
1 condition
4 sponsors
1 location
NCT05377957
Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients
N/A
Recruiting
500 participants
Started: Mar 5, 2019 · Completed: Sep 1, 2030
1 condition
1 sponsor
1 location
NCT06812702
Parkinson's Disease Biomarker Study
N/A
Recruiting
295 participants
Started: Mar 5, 2019 · Completed: Dec 31, 2025
2 conditions
1 sponsor
5 locations
NCT03795337
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II)
NA
Active, not recruiting
475 participants
Started: Mar 5, 2019 · Completed: Dec 31, 2025
1 condition
3 sponsors
8 locations
NCT03889132
Glucose, Brain and Microbiota
N/A
Active, not recruiting
128 participants
Started: Mar 5, 2019 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
2138
2139
2140
2141
2142
2143
2144
More pages
2369
Next